AIM ImmunoTech Inc. (AMEX:AIM) Q3 2023 Earnings Call Transcript

Edward Woo: Great. As you manufacture this 10,000 vial lock, is the cost about the same as it was before? Has it gone up? Has it gone down?

Thomas Equels: Unfortunately, inflation has an even greater toll in our industry. So not only have clinical costs gone up and manufacturing costs have gone up as well. However, we are managing those expenses in a prudent manner. And we need to remember, too, that the manufacturing, well these are — it may sound like a lot of Ampligen, but this is not a mass production type of manufacturing. These are small batches of Ampligen, which cost a lot more to manufacture than it would cost if it were in mass production mode. The price of the Ampligen — the cost of the Ampligen would drop significantly if it were picked up by a company that was in a position to make large amounts of Ampligen.

Edward Woo: Great. Well, thanks for answering my questions and I wish you guys good luck. Thank you.

Thomas Equels: Well, thank you very much Ed.

Operator: Thank you. This concludes our question-and-answer session. I’ll turn the floor back to Mr. Equels for any final comments.

Thomas Equels: Well, as always, we are grateful for your time and your interest in AIM and in Ampligen. We’re very proud of our accomplishments and the accomplishments of our collaborators as we go forward. And on that foundation, we’ll continue to build progress through 2023. We are very much looking forward to pursuing and heightening this momentum in 2024, and providing — and this is perhaps the most important thing to us, providing hope and opportunity for patients who have unmet medical needs in these serious diseases. We look forward to working with our medical collaborators, our scientific collaborators and those universities that are so important to what we’re doing and creating long-term value for our stockholders. Thank you very much.

Operator: Thank you. This concludes today’s conference call. You may disconnect your lines at this time. Thank you for your participation.